Navigation Links
PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
Date:3/17/2009

eform Act of 1995 (the "Act") and are subject to a variety of risks and uncertainties. Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Such forward-looking statements include PharmaNet Development Group, Inc.'s decision to enter into an agreement to be acquired by JLL, the ability of PharmaNet Development Group, Inc. and JLL to complete the transaction contemplated by the definitive agreement, including the parties' ability to satisfy the conditions set forth in the merger agreement, and the possibility of any termination of the definitive agreement. The forward-looking statements contained in this press release are based on the current expectations of PharmaNet, and those made at other times will be based on PharmaNet's expectations when the statements are made. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, the expected timetable for completing the proposed transaction, the risk and uncertainty in connection with a strategic alternative process, not having sufficient funds to pay the principal due upon conversion of the outstanding notes or to repurchase PharmaNet's outstanding notes, which PharmaNet may be required to do beginning in August 2009, the impact of the current economic environment, the impact of PharmaNet's indebtedness on its financial condition or results of operations and the terms of its outstanding indebtedness limiting its activities, the impact of the investigation by the Securities and Exchange Commission, its limited insurance coverage in connection with the settled securities class action lawsuit, limited additional coverage for the recently settled derivative actions and associated future legal fees, the potential liability related to the recently filed securitie
'/>"/>
SOURCE PharmaNet Development Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
2. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
3. PharmaNet Development Group Agrees to be Acquired by JLL Partners
4. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
5. Med Discovery and Laborium Biopharma Extend Their Development Partnership to Include Mammalian Cell Culture Processes and Clinical Manufacturing for All Products in Med Discovery's Portfolio
6. Michael J. Fox Foundation Commits Up To $5 Million for Pre-Clinical Drug Development Under Industry-Exclusive Therapeutics Development Initiative
7. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
8. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
9. AMDL, Inc. Enters Into Collaboration Agreement to Advance Development of Its AMDL DR-70 (FDP) Cancer Test
10. Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
11. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Mass. , Sept. 22, 2014 ... GEVA ), a biopharmaceutical company developing therapeutic ... of Robert Bazemore as Chief Operating ... , President and Chief Executive Officer, Robert will ... company,s lead program, sebelipase alfa for LAL Deficiency, ...
(Date:9/21/2014)... have discovered how to produce ultra-thin "diamond nanothreads" that ... that of today,s strongest nanotubes and polymers. A paper ... John V. Badding, a professor of chemistry at Penn ... 2014 issue of the journal Nature Materials . ... is intriguing because the threads we formed have a ...
(Date:9/20/2014)... Austin, Texas (PRWEB) September 20, 2014 ... of integrated urological and interventional radiology products and ... Endocare, Inc. subsidiary with Clinicon Corporation ... addition expands HealthTronics’ portfolio of minimally invasive, mobile, ... their patients. , Under the agreement, HealthTronics will ...
(Date:9/19/2014)... is rarely simple. From crop yields to disease risks, ... those considered "complex traits." Just as for heightthe textbook ... particular human disease are shaped by multiple genetic and ... involved. To track down such genes, geneticists typically mate ... large mouse and a small mouseand then study their ...
Breaking Biology Technology:Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Want to link genes to complex traits? Start with more diversity 2
... , , , ... IDIX ), a biopharmaceutical company engaged in the discovery ... today announced the pricing of an underwritten offering of 7,248,936 shares ... After underwriting discounts and commissions and estimated offering expenses, the company ...
... HALIFAX, NS, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies ... signed an agreement with UK-based Scancell Ltd., the ... is developing therapeutic cancer and infectious disease vaccines. ... using IVT,s DepoVax(TM) delivery system for Scancell,s novel ...
... ... Park, Fla., will demonstrate how its partnership with AeroClave, LLC, can help stop the ... mitigate the threat of healthcare-associated infections such as MRSA and contagious pathogens including H1N1 ... ...
Cached Biology Technology:Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock 2ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery 2Winter Park Home to World's Foremost Producers of Large-Scale Decontamination Equipment 2
(Date:9/22/2014)... a key molecular cog in a plant,s biological clock ... rhythms based on temperature. , Transcription factors, or genetic ... stresses such as light, rain, soil quality, or ... at USC has isolated one, called FBH1, that reacts ... as needed while in keeping it on a consistent ...
(Date:9/22/2014)... is one of seven institutions in the country ... to receive this year,s BEST Award a ... the university,s most promising biomedical sciences graduate trainees ... path that they have traditionally taken. , The ... Opportunities for Biomedical Scientists (iJOBs) program. It includes ...
(Date:9/22/2014)... (September 22, 2014) Additive manufacturing (AM), or ... the production of complex-shaped metal components strong enough ... fewer errors and distortions, as well as quality ... kept pace with the technology. Engineers at the ... proposing to develop enhanced modeling and simulation (M&S) ...
Breaking Biology News(10 mins):Genetic switch regulates a plant's internal clock based on temperature 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3Pitt engineers receive grants to enhance additive manufacturing 2Pitt engineers receive grants to enhance additive manufacturing 3
... Brazil are more susceptible to toxoplasmosis than those in ... in Austria, Brazil, Denmark, France, Italy, Poland, Sweden, ... in children from birth to four years of age. ... journal PLoS Neglected Tropical Diseases . ...
... the body regulates blood pressure in response to daily ... helping people whose pressure is out of control. ... pressure is not controlled despite the best efforts of ... director of the Georgia Prevention Institute at the Medical ...
... of Angelman syndrome, a neurological disorder that causes mental ... births, has been developed by biologists at The University ... when a particular fruit fly gene, dube3a, is altered, ... experienced by humans whose UBE3A gene doesn,t function normally. ...
Cached Biology News:Blood pressure response to daily stress provides clues for better hypertension treatment 2Blood pressure response to daily stress provides clues for better hypertension treatment 3Blood pressure response to daily stress provides clues for better hypertension treatment 4Blood pressure response to daily stress provides clues for better hypertension treatment 5Blood pressure response to daily stress provides clues for better hypertension treatment 6Model for angelman syndrome developed by University of Texas at Austin biologists 2
... number of modifications of Grace's medium were ... 1960's and 1970's. Many of these modifications ... the growth of cells derived from the ... modification known as TNM-FH. The medium when ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Biology Products: